PNPLA3 and HLA-DQB1 polymorphisms are associated with hepatocellular carcinoma after hepatitis C virus eradication
Daiki Miki(Hiroshima University), C. Nelson Hayes(Hiroshima University), Michio Imamura(Hiroshima University), Norio Akuta(Toranomon Hospital), Hidenori Toyoda(Ogaki Municipal Hospital), Masataka Tsuge(Hiroshima University), Yoshiyasu Karino(Sapporo Kosei General Hospital), Tomokazu Kawaoka(Hiroshima University), Junko Tanaka(Hiroshima University), Hiroshi Aikata(Hiroshima Prefectural Hospital), Masataka Seike(Oita University), Koichi Honda(Yamagata University), Takashi Kumada(Gifu Kyoritsu University), Shuhei Hige(Yamagata University), Tomoyuki Akita(Hiroshima University), Akemi Kurisu(Hiroshima University), Mariko Kobayashi(Toranomon Hospital), Hiromitsu Kumada(Toranomon Hospital), Akira Hiramatsu(Hiroshima University), Tomoaki Nakajima(Sapporo Kosei General Hospital)
Cited by 13
Related Papers
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664